Cargando…

Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma()()

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with a median survival of 12 to 15 months after diagnosis. Acquired chemoresistance, high systemic toxicity, and low penetration of the blood brain barrier by many anticancer drugs contribute to the failure of anti-GBM therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrero, Luis, Wyczechowska, Dorota, Musto, Alberto E., Wilk, Anna, Vashistha, Himanshu, Zapata, Adriana, Walker, Chelsey, Velasco-Gonzalez, Cruz, Parsons, Christopher, Wieland, Scott, Levitt, Daniel, Reiss, Krzysztof, Prakash, Om
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212249/ https://www.ncbi.nlm.nih.gov/pubmed/25379024 http://dx.doi.org/10.1016/j.neo.2014.08.015

Ejemplares similares

Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
por: Da Ros, Martina, et al.
Publicado: (2018)

Pharmacokinetic study of aldoxorubicin in patients with solid tumors
por: Mita, Monica M., et al.
Publicado: (2014)

Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
por: Gong, Jun, et al.
Publicado: (2018)

Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
por: Cranmer, Lee D
Publicado: (2019)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug
por: Sharpe, Martyn A., et al.
Publicado: (2015)

Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma
por: Garrett, Matthew C., et al.
Publicado: (2020)

Attenuated Negative Feedback in Monocyte-Derived Macrophages From Persons Living With HIV: A Role for IKAROS
por: Faia, Celeste, et al.
Publicado: (2021)

Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
por: Shen, Yuanyuan, et al.
Publicado: (2017)

Intracranial AAV‐IFN‐β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
por: GuhaSarkar, Dwijit, et al.
Publicado: (2017)

A Patient-Derived Xenograft Model of Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2020)

Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells
por: Grabacka, Maja M., et al.
Publicado: (2016)

The development of xenograft glioblastoma implants in nude mice brain
por: Behar, FM, et al.
Publicado: (2008)

Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013)

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
por: Sudha, Thangirala, et al.
Publicado: (2017)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
por: Donoghue, Jacqueline F., et al.
Publicado: (2011)

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts
por: McCord, Matthew, et al.
Publicado: (2022)

Transgenic expression of Notch-1 intracellular active domain (N1IC) in T cells: a potential therapy to overcome suppression induced by tumors
por: Sierra, Rosa A, et al.
Publicado: (2013)

Intracranial Glioblastomas: New Hope for an Effective Treatment
por: Cooper, Arthur J.L.
Publicado: (2015)

Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI
por: Boult, Jessica K.R., et al.
Publicado: (2017)

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential()()
por: Stalinska, J., et al.
Publicado: (2019)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts
por: Koessinger, Anna L., et al.
Publicado: (2020)

Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish
por: Ai, Xiaolin, et al.
Publicado: (2022)

Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts
por: Almstedt, Elin, et al.
Publicado: (2021)

Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs
por: Yao, Zhipeng, et al.
Publicado: (2022)

Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme
por: Hernán Pérez de la Ossa, Dolores, et al.
Publicado: (2013)

STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
por: Kim, Byung-Hak, et al.
Publicado: (2020)

Vaccine hesitancy in the post-vaccination COVID-19 era: a machine learning and statistical analysis driven study
por: Gupta, Himanshu, et al.
Publicado: (2022)

Idiopathic gigantomastia with Pseudoangiomatous stromal hyperplasia: A case report
por: Vashistha, Aakansha, et al.
Publicado: (2020)

Glioblastoma and intracranial aneurysms: Case report and review of literature
por: Ali, Rushna, et al.
Publicado: (2015)

Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma
por: Zhang, Junwen, et al.
Publicado: (2020)

Lion in Sheep’s Clothing: Glioblastoma Mimicking Intracranial Hemorrhage
por: Broka, Andrea, et al.
Publicado: (2021)

Intracranial delivery of synthetic mRNA to suppress glioblastoma
por: Peng, Hao, et al.
Publicado: (2021)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2017)

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018)

Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells
por: Chou, Yu-Cheng, et al.
Publicado: (2018)

Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
por: Jin, Fa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r2vvqph2pi2u41a5nuvd9iahqe